Abstract
The fetal cells in primordial organs have the ability to make terminally differentiated cells within the context of embryonic development and organogenesis. Recent advances in the stem cell field confirm the reprogramming capacity of fetal cells to transform into the different cells of the same or other lineages under specific cellular environments called ‘niche.’ In particular, cells existing in primordial organs show multipotent or pluripotent properties, which further emphasizes the importance of these cells in regenerative medicine and tissue engineering in both humans and animals. Reprogramming fetal cells involves manipulations of genetic configuration and changes in both cellular and acellular microenvironments. While this technology is widely used to establish transplantable reprogrammed cells and their derivatives to regenerate or replace damaged tissues, careful considerations should be made in terms of genetic and cellular plasticity as well as anticipated ethical issues. In this chapter, general concepts of fetal cell reprogramming and subsequent phenotypic transformation are reviewed to understand genetic and cellular aspects of cellular plasticity. Potential feasibility of fetal cell manipulation with the consideration of ethical issues has been described subsequently.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMP:
-
Bone morphogenetic protein
- cDNA:
-
Complementary DNA
- CFFs:
-
Colony forming fibroblasts
- CPP:
-
Cell penetrating protein
- DNA:
-
Deoxyribonucleic acid
- ECCs:
-
Embryonic carcinoma cells
- EGCs:
-
Embryonic germ cells
- EMT:
-
Epithelial-to-mesenchymal transition
- ESCs:
-
Embryonic stem cells
- FACS:
-
Fluorescent activated cell sorter
- FGF:
-
Fibroblast growth factor
- FSCs:
-
Fetal stem cells
- GDNF:
-
Glial-derived neurotrophic factor
- HIV:
-
Human immunodeficiency virus
- HSCs:
-
Hematopoietic stem cells
- iPSCs:
-
Induce pluripotent stem cells
- MACS:
-
Magnetic activated cell sorter
- MET:
-
Mesenchymal-to-epithelial transition
- miRNA:
-
microRNA
- MMLV:
-
Moloney murine leukemia virus
- mRNA:
-
Messenger RNA
- MSCs:
-
Mesenchymal stem cells
- NSCs:
-
Neural stem cells
- PB:
-
Piggyback
- PGCs:
-
Primordial germ cells
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SCNT:
-
Somatic cell nuclear transfer
- SLAM:
-
Signaling lymphocyte activation molecule
- SNP:
-
Single-nucleotide polymorphism
- SOP:
-
Standard operation protocol
- SSCs:
-
Spermatogonial stem cells
- TGF:
-
Transforming growth factor
- UCB:
-
Umbilical cord blood
References
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.
Wernig M, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448(7151):318–24.
Brambrink T, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008;2(2):151–9.
Sommer CA, et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells. 2009;27(3):543–9.
Fusaki N, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):348–62.
Stadtfeld M, et al. Induced pluripotent stem cells generated without viral integration. Science. 2008;322(5903):945–9.
Wilson MH, Coates CJ, George Jr AL. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther. 2007;15(1):139–45.
Okita K, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949–53.
Gonzalez F, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A. 2009;106(22):8918–22.
Yu J, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797–801.
Hu K. All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. Stem Cells Dev. 2014;23(12):1285–300.
Si-Tayeb K, et al. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol. 2010;10:81.
Narsinh KH, et al. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc. 2011;6(1):78–88.
Warren L, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618–30.
Anokye-Danso F, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 2011;8(4):376–88.
Freberg CT, et al. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell. 2007;18(5):1543–53.
Kim D, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4(6):472–6.
Hansis C, et al. Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr Biol. 2004;14(16):1475–80.
Ding X, et al. The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Stem Cells Dev. 2014;23(9):931–40.
Kabouridis PS. Biological applications of protein transduction technology. Trends Biotechnol. 2003;21(11):498–503.
Sandgren S, Cheng F, Belting M. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J Biol Chem. 2002;277(41):38877–83.
Liang G, He J, Zhang Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol. 2012;14(5):457–66.
Hou P, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341(6146):651–4.
Kono T. Nuclear transfer and reprogramming. Rev Reprod. 1997;2(2):74–80.
Wakayama T, et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science. 2001;292(5517):740–3.
Byrne JA, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450(7169):497–502.
Wakayama T, et al. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature. 1998;394(6691):369–74.
Couldrey C, Lee RS. DNA methylation patterns in tissues from mid-gestation bovine foetuses produced by somatic cell nuclear transfer show subtle abnormalities in nuclear reprogramming. BMC Dev Biol. 2010;10:27.
Ross PJ, Cibelli JB. Bovine somatic cell nuclear transfer. Methods Mol Biol. 2010;636:155–77.
Cowan CA, et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005;309(5739):1369–73.
Obokata H, et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature. 2014;505(7485):641–7.
Lee ST, et al. Transformation of somatic cells into stem cell-like cells under a stromal niche. Faseb J. 2013;27(7):2644–56.
Tan KY, et al. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One. 2011;6(10):e26406.
Kleger A, et al. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. Gastroenterology. 2012;142(4):907–17.
Eminli S, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet. 2009;41(9):968–76.
Hansel MC, et al. Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions. Cell Transplant. 2014;23(1):27–38.
Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell. New York: Garland Science; 2002.
Twyman R. Developmental biology. Oxford: Bios Scientific Publishers; 2001.
Cinalli RM, Rangan P, Lehmann R. Germ cells are forever. Cell. 2008;132(4):559–62.
Kunwar PS, Lehmann R. Developmental biology: germ-cell attraction. Nature. 2003;421(6920):226–7.
Ginsburg M, Snow MH, McLaren A. Primordial germ cells in the mouse embryo during gastrulation. Development. 1990;110(2):521–8.
Lawson KA, et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 1999;13(4):424–36.
Ying Y, Qi X, Zhao GQ. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci U S A. 2001;98(14):7858–62.
Mei J, et al. C1q-like factor, a target of miR-430, regulates primordial germ cell development in early embryos of Carassius auratus. Int J Biol Sci. 2013;10(1):15–24.
Magnusdottir E, et al. A tripartite transcription factor network regulates primordial germ cell specification in mice. Nat Cell Biol. 2013;15(8):905–15.
Okamura D, et al. REST and its downstream molecule Mek5 regulate survival of primordial germ cells. Dev Biol. 2012;372(2):190–202.
Childs AJ, et al. LIN28 is selectively expressed by primordial and pre-meiotic germ cells in the human fetal ovary. Stem Cells Dev. 2012;21(13):2343–9.
Leitch HG, Smith A. The mammalian germline as a pluripotency cycle. Development. 2013;140(12):2495–501.
Leitch HG, Tang WW, Surani MA. Primordial germ-cell development and epigenetic reprogramming in mammals. Curr Top Dev Biol. 2013;104:149–87.
Monk M. A stem-line model for cellular and chromosomal differentiation in early mouse-development. Differentiation. 1981;19(2):71–6.
Monk M, et al. Preimplantation sexing and diagnosis of hypoxanthine phosphoribosyl transferase deficiency in mice by biochemical microassay. Am J Med Genet. 1990;35(2):201–5.
Pesce M, et al. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev. 1998;71(1–2):89–98.
Shim H, Anderson GB. In vitro survival and proliferation of porcine primordial germ cells. Theriogenology. 1998;49(3):521–8.
Resnick JL, et al. Long-term proliferation of mouse primordial germ cells in culture. Nature. 1992;359(6395):550–1.
Nagy A, Nagy K, Gertsenstein M. Production of mouse chimeras by aggregating pluripotent stem cells with embryos. Methods Enzymol. 2010;476:123–49.
Gardner RL. Clonal analysis of early mammalian development. Philos Trans R Soc Lond B Biol Sci. 1985;312(1153):163–78.
Gardner RL. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature. 1968;220(5167):596–7.
Gardner RL, Rossant J. Investigation of the fate of 4-5 day post-coitum mouse inner cell mass cells by blastocyst injection. J Embryol Exp Morphol. 1979;52:141–52.
Wang ZQ, et al. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev. 1997;62(2):137–45.
Nichols J, Smith A. Naive and primed pluripotent states. Cell Stem Cell. 2009;4(6):487–92.
Matsui Y, Zsebo K, Hogan BL. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell. 1992;70(5):841–7.
Leitch HG, et al. Embryonic germ cells from mice and rats exhibit properties consistent with a generic pluripotent ground state. Development. 2010;137(14):2279–87.
Sharova LV, et al. Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains. Dev Biol. 2007;307(2):446–59.
Durcova-Hills G, Surani A. Reprogramming primordial germ cells (PGC) to embryonic germ (EG) cells. Curr Protoc Stem Cell Biol. 2008;Chapter 1:Unit1A3.
Turnpenny L, et al. Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells. Stem Cells. 2006;24(2):212–20.
Leitch HG, et al. Rebuilding pluripotency from primordial germ cells. Stem Cell Rep. 2013;1(1):66–78.
Johnson L. Efficiency of spermatogenesis. Microsc Res Tech. 1995;32(5):385–422.
Ryu BY, et al. Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat. Proc Natl Acad Sci U S A. 2005;102(40):14302–7.
Itman C, et al. All in the family: TGF-beta family action in testis development. Reproduction. 2006;132(2):233–46.
Oatley JM, Brinster RL. Regulation of spermatogonial stem cell self-renewal in mammals. Annu Rev Cell Dev Biol. 2008;24:263–86.
Barrios F, et al. Opposing effects of retinoic acid and FGF9 on Nanos2 expression and meiotic entry of mouse germ cells. J Cell Sci. 2010;123(Pt 6):871–80.
Tegelenbosch RA, de Rooij DG. A quantitative study of spermatogonial multiplication and stem cell renewal in the C3H/101 F1 hybrid mouse. Mutat Res. 1993;290(2):193–200.
Sato T, et al. In vitro sperm production from mouse spermatogonial stem cell lines using an organ culture method. Nat Protoc. 2013;8(11):2098–104.
Jung JG, et al. Development of novel markers for the characterization of chicken primordial germ cells. Stem Cells. 2005;23(5):689–98.
Jung JG, et al. Identification, culture, and characterization of germline stem cell-like cells in chicken testes. Biol Reprod. 2007;76(1):173–82.
Urven LE, et al. Differential gene expression in fetal mouse germ cells. Biol Reprod. 1993;48(3):564–74.
Clermont Y, Perey B. Quantitative study of the cell population of the seminiferous tubules in immature rats. Am J Anat. 1957;100(2):241–67.
Kluin PM, de Rooij DG. A comparison between the morphology and cell kinetics of gonocytes and adult type undifferentiated spermatogonia in the mouse. Int J Androl. 1981;4(4):475–93.
Yoshida S, et al. The first round of mouse spermatogenesis is a distinctive program that lacks the self-renewing spermatogonia stage. Development. 2006;133(8):1495–505.
Roosen-Runge EC, Giesel Jr LO. Quantitative studies on spermatogenesis in the albino rat. Am J Anat. 1950;87(1):1–30.
Clermont Y, Leblond CP. Renewal of spermatogonia in the rat. Am J Anat. 1953;93(3):475–501.
Monesi V. Autoradiographic study of DNA synthesis and the cell cycle in spermatogonia and spermatocytes of mouse testis using tritiated thymidine. J Cell Biol. 1962;14:1–18.
Clermont Y, Bustos-Obregon E. Re-examination of spermatogonial renewal in the rat by means of seminiferous tubules mounted “in toto”. Am J Anat. 1968;122(2):237–47.
Dym M, Clermont Y. Role of spermatogonia in the repair of the seminiferous epithelium following x-irradiation of the rat testis. Am J Anat. 1970;128(3):265–82.
Clermont Y, Hermo L. Spermatogonial stem cells in the albino rat. Am J Anat. 1975;142(2):159–75.
Clermont Y, Leblond CP. Differentiation and renewal of spermatogonia in the monkey, Macacus rhesus. Am J Anat. 1959;104:237–73.
Clermont Y, Antar M. Duration of the cycle of the seminiferous epithelium and the spermatogonial renewal in the monkey Macaca arctoides. Am J Anat. 1973;136(2):153–65.
Tilly JL, Johnson J. Recent arguments against germ cell renewal in the adult human ovary: is an absence of marker gene expression really acceptable evidence of an absence of oogenesis? Cell Cycle. 2007;6(8):879–83.
Tilly JL, Telfer EE. Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Mol Hum Reprod. 2009;15(7):393–8.
Zheng W, Zhang H, Liu K. The two classes of primordial follicles in the mouse ovary: their development, physiological functions, and implications for future research. Mol Hum Reprod. 2014;20(4):286–92.
Johnson J, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428(6979):145–50.
Johnson J, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122(2):303–15.
Kim IW, et al. Derivation of developmentally competent oocytes by the culture of preantral follicles retrieved from adult ovaries: maturation, blastocyst formation, and embryonic stem cell transformation. Fertil Steril. 2009;92(5):1716–24.
Choi JH, et al. Generation of viable embryos and embryonic stem cell-like cells from cultured primary follicles in mice. Biol Reprod. 2011;85(4):744–54.
Lenie S, et al. A reproducible two-step culture system for isolated primary mouse ovarian follicles as single functional units. Biol Reprod. 2004;71(5):1730–8.
Cortvrindt R, Smitz J, Van Steirteghem AC. Assessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Hum Reprod. 1997;12(4):759–68.
Makris A, Ryan KJ. Progesterone, androstenedione, testosterone, estrone, and estradiol synthesis in hamster ovarian follicle cells. Endocrinology. 1975;96(3):694–701.
Cecconi S, et al. In vitro development of sheep preantral follicles. Biol Reprod. 1999;60(3):594–601.
Echternkamp SE, et al. Ovarian follicular development in cattle selected for twin ovulations and births. J Anim Sci. 2004;82(2):459–71.
Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986;1(2):81–7.
Liu J, et al. Maturation of mouse primordial follicles by combination of grafting and in vitro culture. Biol Reprod. 2000;62(5):1218–23.
Cortvrindt R, Smitz J, Van Steirteghem AC. In-vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepuberal mice in a simplified culture system. Hum Reprod. 1996;11(12):2656–66.
Eppig JJ, Schroeder AC. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro. Biol Reprod. 1989;41(2):268–76.
Choi JK, Agarwal P, He X. In vitro culture of early secondary preantral follicles in hanging drop of ovarian cell-conditioned medium to obtain MII oocytes from outbred deer mice. Tissue Eng Part A. 2013;19(23–24):2626–37.
Sadeu JC, Adriaenssens T, Smitz J. Expression of growth differentiation factor 9, bone morphogenetic protein 15, and anti-Mullerian hormone in cultured mouse primary follicles. Reproduction. 2008;136(2):195–203.
Lee ST, et al. Establishment of autologous embryonic stem cells derived from preantral follicle culture and oocyte parthenogenesis. Fertil Steril. 2008;90(5):1910–20.
Gong SP, et al. Improved establishment of autologous stem cells derived from preantral follicle culture and oocyte parthenogenesis. Stem Cells Dev. 2008;17(4):695–712.
Adriaens I, Cortvrindt R, Smitz J. Differential FSH exposure in preantral follicle culture has marked effects on folliculogenesis and oocyte developmental competence. Hum Reprod. 2004;19(2):398–408.
Revazova ES, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2007;9(3):432–49.
Cibelli JB, et al. Parthenogenetic stem cells in nonhuman primates. Science. 2002;295(5556):819.
Hirabayashi M, et al. Derivation of embryonic stem cell lines from parthenogenetically developing rat blastocysts. Stem Cells Dev. 2014;23(2):107–14.
Kaufman MH, Barton SC, Surani MA. Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature. 1977;265(5589):53–5.
Kaufman MH, et al. Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol. 1983;73:249–61.
Gong SP, et al. Change in gene expression of mouse embryonic stem cells derived from parthenogenetic activation. Hum Reprod. 2009;24(4):805–14.
Kawahara M, et al. High-frequency generation of viable mice from engineered bi-maternal embryos. Nat Biotechnol. 2007;25(9):1045–50.
Mai Q, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res. 2007;17(12):1008–19.
Ju JY, et al. Establishment of stem cell lines from nuclear transferred and parthenogenetically activated mouse oocytes for therapeutic cloning. Fertil Steril. 2008;89(5 Suppl):1314–23.
Navarro P, et al. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol. 1991;115(2):517–33.
Onder TT, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645–54.
Davies JA. Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat (Basel). 1996;156(3):187–201.
Nakaya Y, et al. Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. Dev Cell. 2004;7(3):425–38.
Nakajima Y, et al. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec. 2000;258(2):119–27.
Li B, et al. Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation. PLoS One. 2011;6(2):e17092.
Samavarchi-Tehrani P, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 2010;7(1):64–77.
Yori JL, et al. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem. 2010;285(22):16854–63.
Lim JM, Gong SP. Somatic cell transformation into stem cell-like cells induced by different microenvironments. Organogenesis. 2013;9(4):245–8.
Chang HY, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A. 2002;99(20):12877–82.
Lindvall O. Neural transplantation: a hope for patients with Parkinson’s disease. Neuroreport. 1997;8(14):3–10.
Kordower JH, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N Engl J Med. 1995;332(17):1118–24.
Abdulrazzak H, et al. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface. 2010;7 Suppl 6:S689–706.
De Coppi P, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100–6.
Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 2008;112(9):3543–53.
Linch DC, et al. Studies of circulating hemopoietic progenitor cells in human fetal blood. Blood. 1982;59(5):976–9.
Zauli G, et al. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions. Br J Haematol. 1994;86(3):461–7.
Tocci A, et al. CD34+ cells from first-trimester fetal blood are enriched in primitive hemopoietic progenitors. Am J Obstet Gynecol. 2003;188(4):1002–10.
Shields LE, Andrews RG. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol. 1998;178(5):931–7.
Campagnoli C, et al. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood. 2000;95(6):1967–72.
Clapp DW, et al. Molecular evidence that in situ-transduced fetal liver hematopoietic stem/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood. 1995;86(6):2113–22.
Lim FT, Kanhai HH, Falkenburg JH. Characterization of the human CD34+ hematopoietic progenitor cell compartment during the second trimester of pregnancy. Haematologica. 2005;90(2):173–9.
Oguro H, Ding L, Morrison SJ. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell. 2013;13(1):102–16.
Wagner-Souza K, et al. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells. Int J Mol Med. 2008;22(2):237–42.
Chou BK, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011;21(3):518–29.
Broxmeyer HE, et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood. 2011;117(18):4773–7.
Rollini P, et al. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood. 2004;103(3):1166–70.
Gallacher L, et al. Identification of novel circulating human embryonic blood stem cells. Blood. 2000;96(5):1740–7.
Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999;27(9):1418–27.
Nava S, et al. Characterization of cells in the developing human liver. Differentiation. 2005;73(5):249–60.
Delaney C, Ratajczak MZ, Laughlin MJ. Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol. 2010;3(3):273–83.
McGuckin CP, et al. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res. 2004;295(2):350–9.
Campagnoli C, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98(8):2396–402.
Yu M, et al. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol. 2004;124(5):666–75.
Guillot PV, et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells. 2007;25(3):646–54.
Chan J, et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells. 2006;24(8):1879–91.
Kennea NL, et al. Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype. Cell Cycle. 2009;8(7):1069–79.
Zhang ZY, et al. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells. 2009;27(1):126–37.
in’t Anker PS, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88(8):845–52.
Almeida-Porada G, et al. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol. 2002;30(12):1454–62.
Hu Y, et al. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 2003;141(5):342–9.
Ersek A, et al. Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells. Exp Hematol. 2010;38(4):311–20.
Yen BL, et al. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng Part A. 2008;14(1):9–17.
Anchan RM, et al. Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Hum Mol Genet. 2011;20(5):962–74.
Kennea NL, Mehmet H. Neural stem cells. J Pathol. 2002;197(4):536–50.
Uchida N, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97(26):14720–5.
Kim JB, et al. Direct reprogramming of human neural stem cells by OCT4. Nature. 2009;461(7264):649–53.
Kim JB, et al. Oct4-induced pluripotency in adult neural stem cells. Cell. 2009;136(3):411–9.
Gong SP, et al. Embryonic stem cell-like cells established by culture of adult ovarian cells in mice. Fertil Steril. 2010;93(8):2594–601. 2601 e1–9.
Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med. 2009;4(3):423–33.
Johansson M, Ellegren H, Andersson L. Comparative mapping reveals extensive linkage conservation—but with gene order rearrangements—between the pig and the human genomes. Genomics. 1995;25(3):682–90.
Goureau A, et al. Human and porcine correspondence of chromosome segments using bidirectional chromosome painting. Genomics. 1996;36(2):252–62.
Rettenberger G, et al. Visualization of the conservation of synteny between humans and pigs by heterologous chromosomal painting. Genomics. 1995;26(2):372–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lim, J.M., Ahn, J.Y. (2016). Fetal Cell Reprogramming and Transformation. In: Fauza, D., Bani, M. (eds) Fetal Stem Cells in Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3483-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3483-6_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3481-2
Online ISBN: 978-1-4939-3483-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)